venlafaxine hydrochloride has been researched along with Recrudescence in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (17.54) | 18.2507 |
| 2000's | 19 (33.33) | 29.6817 |
| 2010's | 28 (49.12) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hantson, P; Haufroid, V; Volon, B; Willemart, T | 1 |
| Blumberger, DM; Buchalter, ELF; Dixon, D; Karp, JF; Lenze, EJ; Miller, JP; Mulsant, BH; Oughli, HA; Reynolds, CF | 1 |
| Amsterdam, JD; DeRubeis, RJ; Lorenzo-Luaces, L | 1 |
| Braus, DF; Dreimüller, N; Elsner, S; Engel, A; Lieb, K; Roll, SC; Tadić, A; Wagner, S | 1 |
| Althobaiti, YS | 1 |
| Berk, M; Dodd, S; Kelin, K; Mancini, M; Schacht, A | 1 |
| Etemad, B; Gallop, R; Lohoff, FW; Mandos, LA; Rickels, K; Rynn, MA | 1 |
| Bognár, Z; Gazdag, G; Vonyik, G | 1 |
| Holland, PJ; Keller, MB; Kornstein, SG; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Thase, ME; Trivedi, MH | 1 |
| Begley, A; Butters, MA; Koenig, AM; Ogbagaber, S; Reynolds, CF; Wahed, AS | 1 |
| Carmody, T; Kurian, KR; Lesser, I; Morris, D; Myers, A; Rush, AJ; Toups, M; Trivedi, MH; Warden, D; Zisook, S | 1 |
| del Río-Casanova, L; Díaz-Llenderrozas, F; Portela, B | 1 |
| Beer, AJ; Riepe, MW; Vonend, C; Walther, B | 1 |
| Begley, A; Blumberger, DM; Butters, MA; Dew, MA; Hall, CA; Lenze, EJ; Mulsant, B; Reynolds, CF; Simon, KM; Stack, JA | 1 |
| Aydogdu, IO; Keles, MK; Park, TH; Simsek, T; Yosma, E | 1 |
| Brignone, M; Campbell, R; Cho, SJ; Choi, SE; Francois, C; Jeon, HJ; Jung, R; Milea, D | 1 |
| Aalto-Setälä, M; Brignone, M; Campbell, R; Cure, S; Danchenko, N; Diamand, F; Hallinen, T; Kolasa, K; Koponen, H; Soini, E | 1 |
| Ahmed, S; Dunlop, BW; Friedman, ES; Keller, M; Kocsis, JH; Kornstein, SG; Li, T; Ninan, PT; Pedersen, R; Thase, M; Yan, B | 1 |
| Hardy-Baylé, MC; Passerieux, C | 1 |
| Arellano, J; Baird, J; Benedict, A; De Cock, E | 1 |
| Bergen, H; Cooper, J; Hawton, K; Kapur, N; Murphy, E; Stalker, C; Waters, K | 1 |
| Grønli, O; Olstad, R; Stensland, GØ; Wynn, R | 1 |
| Danchenko, N; Despiegel, N; Maman, K; Marteau, F; Nordström, G | 1 |
| Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Balasubramani, GK; Davis, LL; Fava, M; Gaynes, BN; Howland, RH; Pilkinton, P; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Chang, JS; Ha, K; Ha, TH; Her, JY; Park, T; Yi, SH; Yoo, CS; Yoon, IY | 1 |
| Fava, M; Perlis, RH; Perroud, N; Uher, R | 1 |
| Balasubramani, GK; Kurian, B; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S | 1 |
| Agosti, V; Bisaga, A; Brooks, DJ; Carpenter, KM; Levin, FR; Mariani, J; Nunes, EV; Pavlicova, M; Sullivan, MA | 1 |
| Cooper, T; Haskett, RF; Isenberg, K; McCall, WV; Mulsant, BH; Prudic, J; Rosenquist, PB; Sackeim, HA | 1 |
| Denys, D; Heijnen, CJ; Kavelaars, A; Westenberg, H | 1 |
| Chen, J; Entsuah, AR; Mallick, R; Schatzberg, AF | 1 |
| Iodice, AJ; McCall, WV | 1 |
| Delgado, PL | 1 |
| Kaprinis, G; Kogeorgos, J; Nimatoudis, I; Theodoropoulou, S; Vidalis, A; Zissis, NP | 1 |
| Grignon, S; Trottier, M | 1 |
| Egger, C; Geretsegger, C; Muehlbacher, M; Nickel, M; Stuppaeck, C | 1 |
| Fotiou, F; Fountoulakis, KN; Gerasimou, G; Grammatikos, P; Iacovides, A; Kaprinis, G; Karamouzis, M | 1 |
| Heeren, TJ; Kok, RM; Nolen, WA; Vink, D | 1 |
| Ekman, M; Jönsson, B; Khandker, R; Ovanfors, A; Sobocki, P | 1 |
| Brousse, G; Geneste, J; Llorca, PM; Schmidt, J; Schmitt, A | 1 |
| Nemeroff, CB | 1 |
| Entsuah, AR; Hackett, D; Miska, S; Rudolph, RL | 1 |
| Castañeda, R; Levy, R; Sussman, N; Westreich, LM | 1 |
| Adès, J; Lejoyeux, M | 1 |
| Donnelly, NJ; Khouzam, HR | 1 |
| Amore, M; Ferrari, G; Perez, J; Ricci, M; Zanardi, R | 1 |
| Chouinard, G; Dallal, A | 1 |
| Sharma, V | 1 |
| Emamian, ES; Fatemi, SH; Kist, DA | 1 |
| Nierenberg, AA; Wright, EC | 1 |
| Samuel, RZ | 1 |
| Perry, NK | 1 |
| Guazzelli, M; Nimatoudis, I; Rizzo, F; Smeraldi, E; Tzanakaki, M; Zissis, NP | 1 |
| Culpepper, L | 1 |
11 review(s) available for venlafaxine hydrochloride and Recrudescence
| Article | Year |
|---|---|
Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder.
Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Thiophenes; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
[Venlafaxine-induced delirium mediated by high doses].
Topics: Aged; Antidepressive Agents; Comorbidity; Confusion; Delirium; Depressive Disorder, Major; Dopamine; Dose-Response Relationship, Drug; Drug Substitution; Drug Synergism; Female; Humans; Lorazepam; Models, Neurological; Norepinephrine; Polypharmacy; Psychotropic Drugs; Recurrence; Sertraline; Venlafaxine Hydrochloride | 2015 |
Multiple Subungual Pyogenic Granulomas Following Levothyroxine Treatment.
Topics: Antidepressive Agents, Second-Generation; Female; Follow-Up Studies; Granuloma, Pyogenic; Hormone Replacement Therapy; Humans; Hypothyroidism; Middle Aged; Nail Diseases; Recurrence; Thyroxine; Venlafaxine Hydrochloride | 2015 |
[Mood disorders].
Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Hospitalization; Humans; Male; Mood Disorders; Personality Disorders; Pregnancy; Prognosis; Psychotherapy; Psychotropic Drugs; Recurrence; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Suicide; Time Factors; Venlafaxine Hydrochloride; Young Adult | 2008 |
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Educational Status; Electroconvulsive Therapy; Female; Humans; Kaplan-Meier Estimate; Lithium Carbonate; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Recurrence; Survival Analysis; Venlafaxine Hydrochloride | 2013 |
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
Topics: Algorithms; Ambulatory Care; Analysis of Variance; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Humans; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Terminology as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Common pathways of depression and pain.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Norepinephrine; Pain; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Evolutionary trends in the pharmacotherapeutic management of depression.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Child; Clinical Trials as Topic; Cyclohexanols; Decision Trees; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Piperazines; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Trazodone; Triazoles; Venlafaxine Hydrochloride | 1994 |
Antidepressant discontinuation: a review of the literature.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Incidence; Monoamine Oxidase Inhibitors; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Evolution of remission as the new standard in the treatment of depression.
Topics: Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Mianserin; Mirtazapine; Prevalence; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Generalized anxiety disorder in primary care: emerging issues in management and treatment.
Topics: Adaptation, Psychological; Adolescent; Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Physicians, Family; Prevalence; Primary Health Care; Recurrence; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; United States; Venlafaxine Hydrochloride | 2002 |
22 trial(s) available for venlafaxine hydrochloride and Recrudescence
| Article | Year |
|---|---|
Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History.
Topics: Algorithms; Antidepressive Agents; Anxiety Disorders; Aripiprazole; Clinical Decision Rules; Comorbidity; Delayed-Action Preparations; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Likelihood Functions; Prospective Studies; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression.
Topics: Adult; Antidepressive Agents; Anxiety; Bipolar Disorder; Double-Blind Method; Female; Humans; Lithium Compounds; Male; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride | 2018 |
Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Citalopram; Comorbidity; Depressive Disorder, Major; Drug Substitution; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Psychiatric Status Rating Scales; Recurrence; Retrospective Studies; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Female; Humans; Logistic Models; Male; Middle Aged; Neuroticism; Outcome Assessment, Health Care; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors; Venlafaxine Hydrochloride | 2013 |
Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Menopause; Middle Aged; Placebos; Proportional Hazards Models; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
Topics: Adult; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Placebos; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Depression Remission Rates Among Older Black and White Adults: Analyses From the IRL-GREY Trial.
Topics: Aged; Antidepressive Agents, Second-Generation; Black or African American; Depressive Disorder, Major; Female; Humans; Kaplan-Meier Estimate; Male; Patient Dropouts; Proportional Hazards Models; Recurrence; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; White People | 2015 |
Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Male; Recurrence; Risk Assessment; Time Factors; Treatment Failure; Venlafaxine Hydrochloride | 2008 |
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Personality Inventory; Recurrence; Selective Serotonin Reuptake Inhibitors; Self Report; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
Topics: Adolescent; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Substance-Related Disorders; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Autonomic Nervous System; Case-Control Studies; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Entropy; Female; Heart Rate; Humans; Recurrence; Respiratory Rate; Venlafaxine Hydrochloride | 2012 |
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Bupropion; Child Abuse; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Self Report; Severity of Illness Index; Single-Blind Method; Suicidal Ideation; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Abuse; Medication Adherence; Recurrence; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Venlafaxine Hydrochloride | 2013 |
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Educational Status; Electroconvulsive Therapy; Female; Humans; Kaplan-Meier Estimate; Lithium Carbonate; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Recurrence; Survival Analysis; Venlafaxine Hydrochloride | 2013 |
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
Topics: Algorithms; Ambulatory Care; Analysis of Variance; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Humans; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Terminology as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Greece; Humans; Male; Outpatients; Psychiatric Status Rating Scales; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium Compounds; Male; Middle Aged; Phenelzine; Recurrence; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder.
Topics: Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Double-Blind Method; Humans; Markov Chains; Quality-Adjusted Life Years; Recurrence; Risk Factors; Venlafaxine Hydrochloride | 2008 |
Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 1996 |
Long-term treatment of geropsychiatric depressed patients with venlafaxine.
Topics: Adrenergic Uptake Inhibitors; Age Factors; Aged; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Recurrence; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Recurrence; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Venlafaxine Hydrochloride | 2000 |
26 other study(ies) available for venlafaxine hydrochloride and Recrudescence
| Article | Year |
|---|---|
Recurrence of Serotonin Toxicity and Influence of Cytochrome 2D6 Polymorphism.
Topics: Antidepressive Agents; Cognitive Dysfunction; Cytochrome P-450 CYP2D6; Depression; Humans; Male; Middle Aged; Polymorphism, Genetic; Recurrence; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2019 |
Role of venlafaxine in relapse to methamphetamine seeking. Potential treatment option for drug dependence.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Addictive; Conditioning, Classical; Infusions, Parenteral; Male; Methamphetamine; Motor Activity; Rats, Wistar; Recurrence; Substance-Related Disorders; Venlafaxine Hydrochloride | 2019 |
[Antidepressant treatment associated hyponatremia -- case report].
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Critical Care; Cyclohexanols; Depression; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hyponatremia; Male; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Sodium; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Citalopram; Cognitive Dysfunction; Cyclohexanols; Dementia; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2014 |
Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.
Topics: Aged; Alzheimer Disease; Anticonvulsants; Antidepressive Agents; Attention; Cognition Disorders; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Essential Tremor; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Lithium Compounds; Male; Memory Disorders; Memory, Episodic; Mental Recall; Neuropsychological Tests; Positron-Emission Tomography; Primidone; Radiopharmaceuticals; Recurrence; Venlafaxine Hydrochloride | 2015 |
Cost-effectiveness of vortioxetine versus venlafaxine (extended release) in the treatment of major depressive disorder in South Korea.
Topics: Antidepressive Agents; Cost-Benefit Analysis; Decision Trees; Delayed-Action Preparations; Depressive Disorder, Major; Humans; Markov Chains; Piperazines; Quality-Adjusted Life Years; Recurrence; Republic of Korea; Sulfides; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine | 2016 |
[Continuing therapy also in summer].
Topics: Citalopram; Depressive Disorder; Drug Administration Schedule; Female; Humans; Long-Term Care; Male; Photosensitivity Disorders; Plant Extracts; Recurrence; Seasons; Venlafaxine Hydrochloride | 2016 |
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
Topics: Acetamides; Antidepressive Agents; Bupropion; Cost-Benefit Analysis; Decision Trees; Depressive Disorder, Major; Finland; Humans; Markov Chains; Models, Theoretical; Piperazines; Recurrence; Sertraline; Sulfides; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine | 2017 |
Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.
Topics: Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Duloxetine Hydrochloride; Health Care Costs; Humans; Mianserin; Mirtazapine; Prevalence; Quality of Life; Recurrence; Remission Induction; Scotland; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2010 |
A comparative study of non-fatal self-poisoning with antidepressants relative to prescribing in three centres in England.
Topics: Amitriptyline; Antidepressive Agents; Cross-Sectional Studies; Cyclohexanols; Dothiepin; England; Guideline Adherence; Humans; Odds Ratio; Poisoning; Practice Patterns, Physicians'; Recurrence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Neurotrophic factors in serum following ECT: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Bipolar Disorder; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Growth Factors; Pilot Projects; Psychotherapy; Psychotropic Drugs; Recurrence; Reference Values; Venlafaxine Hydrochloride | 2009 |
Agomelatine: new drug. Adverse effects and no proven efficacy.
Topics: Acetamides; Animals; Antidepressive Agents; Bias; Carcinogens; Clinical Trials as Topic; Cyclohexanols; Depression; Depressive Disorder; Double-Blind Method; Drug Approval; Europe; Fluoxetine; Humans; Hypnotics and Sedatives; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptors, Melatonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Markov Chains; Outcome Assessment, Health Care; Quality-Adjusted Life Years; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sweden; Thiophenes; Venlafaxine Hydrochloride | 2010 |
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride | 2012 |
A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.
Topics: Cyclohexanols; Female; Humans; Lymphocyte Activation; Middle Aged; Obsessive-Compulsive Disorder; Recurrence; Selective Serotonin Reuptake Inhibitors; Sinusitis; T-Lymphocytes; Venlafaxine Hydrochloride | 2002 |
ECT resistance and early relapse: two cases of subsequent response to venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Middle Aged; Patient Care Planning; Recurrence; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Capgras syndrome in the modern era: self misidentification on an ID picture.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Capgras Syndrome; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Olanzapine; Recurrence; Schizophrenia; Self Concept; Social Identification; Venlafaxine Hydrochloride; Visual Perception | 2005 |
A case of recurrent hyponatremia induced by venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Female; Humans; Hyponatremia; Recurrence; Venlafaxine Hydrochloride | 2006 |
Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods?
Topics: Adult; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Dexamethasone; Dexfenfluramine; Dominance, Cerebral; Electrooculography; Electroretinography; Evoked Potentials, Visual; Female; Follow-Up Studies; Globus Pallidus; Humans; Hydrocortisone; Male; Middle Aged; Prognosis; Prolactin; Recurrence; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Recurrent herpes and post-traumatic stress disorder.
Topics: Accidents, Traffic; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Herpes Labialis; Humans; Male; Recurrence; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2007 |
Drug craving and other negative reactions after abrupt substitution of nefazodone for other serotonergic agents.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Paroxetine; Piperazines; Recurrence; Serotonin Agents; Substance-Related Disorders; Triazoles; Venlafaxine Hydrochloride | 1996 |
Remission of traumatic brain injury-induced compulsions during venlafaxine treatment.
Topics: Antidepressive Agents, Second-Generation; Craniotomy; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Head Injuries, Closed; Hematoma, Epidural, Cranial; Humans; Male; Middle Aged; Neurocognitive Disorders; Obsessive-Compulsive Disorder; Postoperative Complications; Recurrence; Venlafaxine Hydrochloride | 1998 |
Venlafaxine: loss of antidepressant effect and its management.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Recurrence; Venlafaxine Hydrochloride | 1998 |
Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Chronic Disease; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Psychiatric Status Rating Scales; Recurrence; Venlafaxine Hydrochloride | 1999 |
Priapism associated with venlafaxine use.
Topics: Adolescent; Cyclohexanols; Depression; Humans; Male; Priapism; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Venlafaxine Hydrochloride | 2000 |
Venlafaxine-induced serotonin syndrome with relapse following amitriptyline.
Topics: Adrenergic Uptake Inhibitors; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Cyclohexanols; Electroencephalography; Humans; Male; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2000 |